Senate bill S607-118

Health, Education, Labor, and Pensions Committee

EFFECTIVE Act

• Last activity on Mar 01, 2023

• Introduced Mar 01, 2023

• By Sen. Manchin, Joe, III [D-WV]

Support this bill

Ensuring the FDA Fully Examines Clinical Trial Impact and Vitalness before Endorsement Act or the EFFECTIVE Act

This bill specifies that the Food and Drug Administration may deny an application for a new opioid analgesic drug (i.e., opioid medication) upon a determination that the drug does not provide a significant advantage with respect to safety or effectiveness as compared to other drugs.

Senate Actions

IntroReferral
Mar. 01 2023	Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Library of Congress Actions

IntroReferral
Mar. 01 2023	Introduced in Senate

Senate bill S607-118

EFFECTIVE Act

Promote the cause!

Or use this QR code